State Street Corp. Maintains Passive Stake in Editas Medicine
Ticker: EDIT · Form: SC 13G/A · Filed: Jan 10, 2024 · CIK: 1650664
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, passive-investment, amendment, biotech
TL;DR
**State Street still owns Editas shares, no big changes here.**
AI Summary
State Street Corporation, a major financial institution, filed an amended SC 13G/A on January 10, 2024, disclosing its ownership in Editas Medicine, Inc. as of December 31, 2023. This filing indicates that State Street continues to hold a significant, though passive, stake in Editas Medicine. For investors, this means a large institutional investor maintains confidence in Editas, which could be a positive signal, but the filing itself doesn't reveal any new strategic moves or changes in their investment thesis.
Why It Matters
This filing confirms State Street Corporation's continued institutional ownership in Editas Medicine, providing transparency on a major holder's position without indicating any active management changes.
Risk Assessment
Risk Level: low — This is a routine update from a passive institutional investor and does not signal any immediate risks or opportunities.
Analyst Insight
An investor should note that a large institution like State Street Corporation continues to hold a stake in Editas Medicine, Inc., which can be seen as a vote of confidence, but this filing alone doesn't suggest any new catalysts or changes in the company's outlook. It's a routine disclosure of passive ownership.
Key Players & Entities
- State Street Corporation (company) — the reporting person and institutional investor
- Editas Medicine, Inc. (company) — the subject company whose securities are being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 10, 2024 (date) — the filing date of the SC 13G/A
FAQ
What type of filing is this and what does it generally indicate?
This is an SC 13G/A filing, which is an amendment to a Schedule 13G. It indicates that an institutional investor, in this case, State Street Corporation, is reporting or updating its passive ownership of 5% or more of a company's stock, Editas Medicine, Inc., as of December 31, 2023.
Who is the reporting person in this filing?
The reporting person is State Street Corporation, with an IRS Identification No. of 04-2456637 and organized in MA, as stated on page 2 of 5.
What is the subject company whose securities are being reported?
The subject company is Editas Medicine, Inc., with a CIK of 0001650664, as detailed in the 'SUBJECT COMPANY' section of the filing.
What is the CUSIP number for the class of securities reported?
The CUSIP number for the Common Stock of Editas Medicine, Inc. is 28106W103, as listed on the cover page and page 2 of 5 of the filing.
What was the date of the event that required this filing?
The date of the event which required the filing of this statement was December 31, 2023, as specified on the cover page of the filing.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 10, 2024 regarding Editas Medicine, Inc. (EDIT).